Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with
mitomycin, doxorubicin, and cisplatin in treating patients with recurrent or advanced cancer
of the uterus.